Get the Stockscreener App
6.14
4.66%
-0.30
Precision Biosciences Inc stock is traded at $6.14, with a volume of 60,482.
It is down -4.66% in the last 24 hours and up +8.10% over the past month.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.
See More
Previous Close:
$6.44
Open:
$6.31
24h Volume:
60,482
Relative Volume:
0.52
Market Cap:
$72.37M
Revenue:
$52.29M
Net Income/Loss:
$-73.52M
P/E Ratio:
-9.303
EPS:
-0.66
Net Cash Flow:
$-100.45M
1W Performance:
-24.75%
1M Performance:
+8.10%
6M Performance:
+18.53%
1Y Performance:
-27.08%
1-Day Range:
$6.07
$6.3243
1-Week Range:
$6.07
$7.74
52-Week Range:
$3.61
$8.82
Precision Biosciences Inc Stock (DTIL) Company Profile
Name
Precision Biosciences Inc
Sector
Industry
Phone
919-314-5512
Address
302 EAST PETTIGREW STREET, DURHAM, NC
Compare DTIL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DTIL
Precision Biosciences Inc
|
6.14 | 85.37M | 52.29M | -73.52M | -100.45M | -0.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.47 | 105.61B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
657.53 | 67.99B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.70 | 58.19B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.65 | 52.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.70 | 39.60B | 447.02M | -1.18B | -906.14M | -6.1812 |
Precision Biosciences Inc Stock (DTIL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-10-25 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Apr-30-24 | Initiated | Guggenheim | Buy |
| Jun-17-22 | Initiated | BMO Capital Markets | Outperform |
| Jun-09-22 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-27-20 | Resumed | BTIG Research | Buy |
| Apr-03-20 | Downgrade | Goldman | Buy → Neutral |
| Mar-05-20 | Initiated | Stifel | Buy |
| Feb-25-20 | Initiated | William Blair | Outperform |
| Aug-09-19 | Initiated | BTIG Research | Buy |
| Jul-16-19 | Initiated | H.C. Wainwright | Buy |
| Apr-22-19 | Initiated | Barclays | Overweight |
| Apr-22-19 | Initiated | Goldman | Buy |
| Apr-22-19 | Initiated | JP Morgan | Overweight |
| Apr-22-19 | Initiated | Jefferies | Buy |
View All
Precision Biosciences Inc Stock (DTIL) Latest News
Is Precision BioSciences Inc. (PBS0) stock a contrarian opportunityEarnings Trend Report & Weekly Stock Breakout Alerts - newser.com
Is Precision BioSciences Inc. (PBS0) stock a top dividend aristocrat candidateMarket Sentiment Report & Growth Focused Stock Reports - newser.com
Has Precision BioSciences Inc. found a price floor2025 Big Picture & Technical Buy Zone Confirmation - newser.com
Is Precision BioSciences Inc. stock gaining market shareJuly 2025 PostEarnings & Weekly Market Pulse Alerts - newser.com
How hedge fund analytics apply to Precision BioSciences Inc. stockProduct Launch & Verified High Yield Trade Plans - newser.com
How Precision BioSciences Inc. stock trades during market volatilityTrade Risk Assessment & Long Hold Capital Preservation Plans - newser.com
Multi asset correlation models including Precision BioSciences Inc.Earnings Summary Report & Safe Capital Growth Stock Tips - newser.com
Momentum divergence signals in Precision BioSciences Inc. chartJuly 2025 Momentum & AI Powered Buy and Sell Recommendations - newser.com
Is Precision BioSciences Inc. stock a defensive play in 2025Market Trend Report & AI Enhanced Trading Signals - newser.com
Earnings visualization tools for Precision BioSciences Inc.Watch List & Weekly Breakout Stock Alerts - newser.com
Detecting price anomalies in Precision BioSciences Inc. with AIJuly 2025 Movers & Precise Swing Trade Entry Alerts - newser.com
Using economic indicators to assess Precision BioSciences Inc. potentialJuly 2025 Intraday Action & Expert Verified Movement Alerts - newser.com
Stock Analysis: Why Precision BioSciences Inc. stock is a value investor pickQuarterly Portfolio Review & AI Powered Buy/Sell Recommendations - fcp.pa.gov.br
What analysts say about Precision BioSciences Inc stockAnalyst Downgrades & Build Your Portfolio With Our Free Stock Scanner - earlytimes.in
Top Analysts Predictions for Npl Chemicals Limited Stock Over 12 MonthsTrade Execution Strategies & Unlock Patterns Humans Can’t See - earlytimes.in
Precision BioSciences (NASDAQ:DTIL) CEO Sells $22,124.41 in Stock - MarketBeat
Imugene Issues Shares to Precision Biosciences Following Milestone Achievement - MSN
symbol__ Stock Quote Price and Forecast - CNN
Precision BioSciences Reports Q3 2025 Financial Results - TipRanks
Will Precision BioSciences Inc. outperform the marketJuly 2025 Institutional & Stepwise Swing Trade Plans - newser.com
Can Precision BioSciences Inc. stock resist market sell offsEntry Point & Verified Technical Trade Signals - newser.com
Is Precision BioSciences Inc. stock positioned well for digital economyCEO Change & Free AI Powered Buy and Sell Recommendations - newser.com
Real time breakdown of Precision BioSciences Inc. stock performanceTrade Analysis Report & Verified Swing Trading Watchlists - newser.com
Precision Biosciences CEO Sells Shares to Cover Tax Obligations - TradingView
[Form 4] PRECISION BIOSCIENCES INC Insider Trading Activity - Stock Titan
Precision BioSciences (NASDAQ:DTIL) Announces Quarterly Earnings Results - MarketBeat
Precision BioSciences: Q3 Earnings Snapshot - CT Insider
Is Precision BioSciences Inc. (PBS0) stock prepared for digital transitionTrade Entry Summary & High Accuracy Trade Alerts - newser.com
Precision BioSciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
Precision BioSciences Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Precision BioSciences (DTIL) Exceeds Q3 Revenue Expectations - GuruFocus
Precision BioSciences Inc Reports Q3 2025 EPS of -$1.84, Missing - GuruFocus
Precision BioSciences Q3 revenue falls sharply - MarketScreener
PRECISION BIOSCIENCES INC SEC 10-Q Report - TradingView
Precision BioSciences Reports Third Quarter 2025 Financial Results and Provides Business Update - Business Wire
[8-K] PRECISION BIOSCIENCES INC Reports Material Event | DTIL SEC FilingForm 8-K - Stock Titan
Precision BioSciences to Report Third Quarter 2025 Financial Results on November 3, 2025 - MarketScreener
Imugene Issues Shares to Precision Biosciences, Marking Milestone Achievement - TipRanks
Precision Biosciences Inc Stock (DTIL) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.44%
0.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):